Vanda Pharmaceuticals is a global biopharmaceutical company headquartered in the Washington DC metropolitan area. Its work is centered on the development and commercialization of therapies for high unmet medical needs, with a primary focus on the central nervous system (CNS). The company operates within the broader biopharmaceutical and healthcare sectors.
The company's technical expertise spans pharmacogenetics, clinical development, and neuroscience. This foundation supports its clinical-stage product pipeline, which targets CNS disorders, orphan diseases, and other conditions with limited existing therapeutic options.
Operationally, Vanda emphasizes rigorous scientific standards and regulatory compliance as core principles. Its stated mission is directed toward making a meaningful difference in patients' lives through its therapeutic programs.
